Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Middle East and Africa Biosimulation Market Size
The global biosimulation market was valued at USD 3.5 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the rising investments in the drug discovery activities. It is expected to grow at a CAGR of 16.90% during the forecast period of 2024-2032, with the values likely to attain USD 14.1 billion by 2032.
Middle East and Africa Biosimulation Market Outlook
- The market size is influenced by the growing adoption of biosimulation techniques to identify potential drug candidates and expedite the development of safer and more targeted treatments with accurate dosing regimen.
- The market is witnessing multiple investment activities aimed at stimulating the growth of the pharmacometrics sector are expected to boost the Middle East and Africa biosimulation market share. Certara, Inc. invested in the Applied Pharmacometrics Training Fellowship program which started in January 2022 , to train African scientists in pharmacometrics and model-based analyses.
- It is estimated that more than 1 in 4 people are affected by non-communicable diseases in Saudi Arabia. This increasing prevalence of diseases is likely to create more emphasis on the adoption of biosimulation techniques, thereby fuelling the market demand.
Middle East and Africa Biosimulation Market Analysis
Biosimulation utilizes computational models and simulations to determine how drugs work, predict side effects and optimal dosing, and design better treatments for diseases. It leverages mathematical and computational techniques to analyze the dynamics of biological systems and how they will respond under different interventions. This approach is increasingly used to identify potential drug candidates due to its ability to accelerate drug development processes in a cost-effective way. The growing interest in in-silico drug discovery is expected to drive the Middle East and Africa biosimulation market growth.
The rising burden of non-communicable diseases also impacts the market dynamics in the region. Recent data states that cardiovascular diseases, cancer, diabetes , and chronic respiratory diseases (amongst four main non-communicable diseases) are responsible for the death of 22,000 people in Saudi Arabia every year. Further, it is estimated that more than 1 in 4 people are affected by any one of the 4 main non-communicable diseases, reflecting the urgent need for effective therapies. This increasing prevalence of diseases is anticipated to create more emphasis on the adoption of biosimulation techniques in order to expedite the development of safer and more targeted treatments. Consequently, this is poised to fuel the Middle East and Africa biosimulation market demand.
One of the major market trends is the increased investment in the pharmacometrics sector, which is likely to augment the demand for biosimulation software and services in the forecast period. For instance, in January 2022, Certara, Inc., a global leader in biosimulation, invested in the Applied Pharmacometrics Training Fellowship program to train African scientists in pharmacometrics and model-based analyses. This investment initiative by Certara in the fellowship program not only stimulates capacity building in Africa but also paves the way for potential market growth opportunities for the company in the region. Other factors such as the rising number of government-backed grants and research funding programs are also contributing to the market growth.
Middle East and Africa Biosimulation Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Software, Services, Others |
| Delivery Model | Subscription Model, Ownership Model, Others |
| Application | Drug Development, Drug Discovery, Others |
| End User | Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes |
| Countries | Saudi Arabia, United Arab Emirates, Nigeria, South Africa, Others |
Leading Players in the Middle East and Africa Biosimulation Market
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific INC.
- BIO-RAD Laboratories
- Illumina, INC.
- QIAGEN
- F. Hoffmann-La Roche LTD.
- Revvity
- Pacbio
- Agilent Technologies, INC.
- Sysmex Corporation
- BGI
- Eurofins Scientific SE
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Delivery Model |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Our Top Selling Reports
Middle East and Africa Biosimulation Market Report Snapshots
Middle East and Africa Biosimulation Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The Middle East and Africa biosimulation market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 16.90% during the forecast period of 2024-2032 and is likely to reach a market value of USD 14.1 billion by 2032.
The rising burden of chronic diseases and the growing interest in in-silico drug discovery is fuelling the demand for the market.
One of the significant trends in the market involves rising investment in the pharmacometrics sector, which is likely to augment the demand for biosimulation software and services. For instance, Certara, Inc., invested in the Applied Pharmacometrics Training Fellowship program which started in January 2022, to train African scientists in pharmacometrics and model-based analyses.
Based on the product, the market is segmented into software and services, among others.
By delivery model, the market is divided into a subscription model and ownership model, among others.
End users of the market are pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes, among others.
Major applications of biosimulation include drug development and drug discovery, others.
The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.
The key players in the market are Thermo Fisher Scientific Inc., BIO-RAD Laboratories, ILLUMINA, INC., QIAGEN, F. Hoffmann-La Roche LTD., REVVITY, PACBIO, AGILENT TECHNOLOGIES, INC., SYSMEX CORPORATION, BGI, and EUROFINS SCIENTIFIC SE.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124